Cevimeline (Evoxac) For Dry Mouth
Cevimeline hydrochloride, an acetylcholine derivative, has been approved by the FDA for treatment of dry mouth symptoms caused by Sjogren's syndrome. Presumably it could also be used to treat radiation-induced xerostomia in patients with head and neck cancer. Pilocarpine hydrochloride is FDA-approved for both indications...
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Cevimeline (Evoxac) For Dry Mouth
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1084
Article Code: 1084b
Date: August 7, 2000
Volume: 42
Page: 70
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1084
Article Code: 1084b
Date: August 7, 2000
Volume: 42
Page: 70
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)